The global Decongestant Market Growing Market Remedies Respiratory Issues


 Decongestants provide relief from sinus and nasal congestion symptoms associated with colds, allergies, and infections. Effective decongestants temporarily relieve blockage and promote nasal drainage through vasoconstriction of blood vessels in nasal mucosa. Commonly used decongestants include pseudoephedrine, phenylephrine, and oxymetazoline.

The global Decongestant Market is estimated to be valued at US$ 4,710.4 Mn in 2023 and is expected to exhibit a CAGR of 18% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Growing popularity of home remedies for temporary relief of cold, flu, and allergies has driven increased adoption of over-the-counter decongestants. Self-medication allows individuals to access convenient decongestant treatment without a prescription. Improved marketing and visibility on e-commerce and retail shelves has raised awareness about decongestant options. Semisolid nasal formulations such as gels and ointments provide targeted localized relief and are gaining market share among consumers seeking non-oral delivery methods. With increasingly busy lifestyles, demand continues to rise for quick and effective decongestant remedies that alleviate symptoms and allow people to resume normal activities promptly.

Segment Analysis

The global decongestant market is dominated by oral decongestants segment accounting for over 55% share in 2021. Oral decongestants are the most common and effective way of reducing nasal congestion caused by common cold and allergies. They come in the form of tablets, capsules and syrups which provide quick relief from blocked/stuffy nose by constricting blood vessels in nasal passages. The easy availability of over-the-counter oral decongestants without prescription makes them the preferred choice among consumers.

Key Takeaways

The global decongestant market is expected to witness high growth over the forecast period of 2023 to 2030 supported by rising incidence of allergic rhinitis and common cold worldwide. The global Decongestant Market is estimated to be valued at US$ 4,710.4 Mn in 2023 and is expected to exhibit a CAGR of 18% over the forecast period 2023 to 2030.

North America currently accounts for the largest market share due to high awareness levels regarding self-medication of seasonal allergies and common cold symptoms. North America is expected to remain the dominant as well as the fastest growing regional market over the forecast period. High prevalence of nasal congestion related issues such as common cold and allergic rhinitis drive the market growth. According to CDC estimates, cold affects Americans on an average 2-3 times every year. Rising healthcare expenditure and high adoption rate of OTC medications for instant relief further boosts the market in the region.

Key players: Key players operating in the decongestant market are Johnson & Johnson, Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Sanofi S.A., Bayer AG, Reckitt Benckiser Group plc, Prestige Consumer Healthcare Inc., Procter & Gamble Co., Sun Pharmaceutical Industries Ltd. Players are focused on developing innovative drug delivery formats such as quick dissolving tablets for improved patient convenience.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more